Brokerage Reports
0 items in cart
Iovance Biotherapeutics, Inc. [IOVA]
Reports for Purchase
Showing records 141 - 160 ( 187 total )
Company: Iovance Biotherapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Price: 24.95
Company: Iovance Biotherapeutics, Inc.
Industry: Medical - Biomedical and Genetics
1Q20 Results; Looking Towards First Two BLAs;
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Price: 25.00
Company: Iovance Biotherapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Moffitt AACR Data Continue to Solidify Targeting NSCLC; Target Increased to $48
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Price: 25.00
Company: Iovance Biotherapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Price: 24.95
Company: Iovance Biotherapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Price: 24.95
Company: Iovance Biotherapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Price: 24.95
Company: Iovance Biotherapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Market Shudders But We See Names to Outperform.
Provider: H.C. Wainwright & Co., Inc.
Analyst: Research Department
Price: 150.00
Company: Iovance Biotherapeutics, Inc.
Industry: Medical - Biomedical and Genetics
2020 Outlook: Data, BLAs and Manufacturing, Oh My; Maybe Even a Takeout? Target Upped to $36
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Price: 25.00
Company: Iovance Biotherapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Busy Week for Iovance Team as BLAs Approach This Year
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Price: 25.00
Company: Iovance Biotherapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Cohort 2 Data in Checkpoint Primary Refractory Population Further Solidifies Our Thesis
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Price: 10.00
Company: Iovance Biotherapeutics, Inc.
Industry: Medical - Biomedical and Genetics
3Q19 Activity and Safety-Centric Validation In-House; Awaiting Mature Data in 2020
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Price: 25.00
Company: Iovance Biotherapeutics, Inc.
Industry: Medical - Biomedical and Genetics
3Q19 Results; Important SITC Update This Weekend; BLAs on Track by YE20; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Price: 25.00
Company: Iovance Biotherapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Investor Breakfast Highlights Full Steam Ahead for All Programs; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Price: 25.00
Company: Iovance Biotherapeutics, Inc.
Industry: Medical - Biomedical and Genetics
2Q19 Results; Building on Novel TIL Opportunities; BLA Filings for Both LN-144 and LN-145 Expected by YE20
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Price: 25.00
Company: Iovance Biotherapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Data, FDA Visibility, and Another Targeted BLA; Priceless
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Price: 10.00
Company: Iovance Biotherapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Our Thoughts Post CAR-T and the Rise of the Cellicon Valley Summit
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHATTOPADHYAY D
Price: 50.00
Company: Iovance Biotherapeutics, Inc.
Industry: Medical - Biomedical and Genetics
TILs Continue to Shine at ASCO; Target Increased to $32
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Price: 25.00
Company: Iovance Biotherapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Further Preparations for Commercial Success; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Price: 10.00
Company: Iovance Biotherapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Shocker (Not), LN-145 Granted Breakthrough Therapy Designation; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Price: 25.00
Company: Iovance Biotherapeutics, Inc.
Industry: Medical - Biomedical and Genetics
ASCO Melanoma Abstract Data Continue to Solidify Confidence in Pivotal Study
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Price: 25.00